Euda Health Holdings to execute 1-for-20 reverse stock split on March 23, 2026

Reuters03-19 17:30
<a href="https://laohu8.com/S/EUDAW">Euda Health</a> Holdings to execute 1-for-20 reverse stock split on March 23, 2026
  • Euda Health will implement a 1-for-20 reverse stock split of its ordinary shares, effective at market open on March 23, 2026.
  • The shares will continue trading on Nasdaq under the symbol EUDA, and the post-split CUSIP will be G3142E147.
  • Outstanding ordinary shares are expected to change from about 50.31 million to about 2.52 million after the consolidation.
  • Warrants will be adjusted so each warrant covers 1/40 of an ordinary share and the exercise price becomes USD 230 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Euda Health Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603190530PRIMZONEFULLFEED9675125) on March 19, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment